Novel, Selective, and Developable Dopamine D₃ Antagonists with a Modified "Amino" Region.

Area of Science:

• Medicinal Chemistry
• Neuroscience
• Pharmacology

Background:

• Dopamine D3 receptor antagonists are investigated for therapeutic applications.
• Early scaffolds required modification in the amine portion for improved properties.
• Selectivity over dopamine D2 receptors and hERG channels is crucial for safety and efficacy.

Purpose of the Study:

• To describe the discovery of novel templates for dopamine D3 receptor antagonists.
• To highlight compounds with high selectivity and a wide therapeutic window.
• To discuss the developability and pharmacokinetic properties of new drug candidates.

Main Methods:

• Modification of early scaffolds in the amine region.
• Synthesis and characterization of novel dopamine D3 receptor antagonist derivatives.
• Evaluation of compound selectivity for dopamine D3 vs. D2 receptors and hERG channels.
• Assessment of physicochemical and pharmacokinetic parameters for drug developability.

Main Results:

• Identification of new compound systems with high selectivity (>2000-fold) for dopamine D3 receptors over dopamine D2 receptors.
• Compounds demonstrated selectivity against the hERG ion channel, a key safety liability.
• Selected derivatives exhibited favorable physicochemical and pharmacokinetic profiles, indicating good developability.

Conclusions:

• Novel templates for dopamine D3 receptor antagonists have been successfully developed.
• The discovered compounds offer high selectivity and a potentially large therapeutic window.
• These findings represent significant progress in the development of safer and more effective D3 receptor antagonists.